Generalized Anxiety Disorder |18-70| Outpatient | Psychedelic
Are you or a loved one living with Generalized Anxiety?
Segal Trials is conducting an outpatient clinical research study investigating the efficacy, safety, and tolerability of psilocybin in those with Generalized anxiety.
Study Details
•Men and women 18 years to 70
• Experiencing Anxiety Symptoms
• Additional criteria may apply
Participants who qualify may receive:
•Study-related exams & lab work at no cost.
•Compensation for time & travel, if qualified.
•No insurance is necessary